Showing results (61-70 of 325) with videos related to
Sort By:
Pageof 33
Journal of the American College of Cardiology|February 1, 1986
Acute and chronic sympathetic reflex activation and antihypertensive response to nifedipineW Kiowski, P Erne, O Bertel, et al.Therapeutische Umschau. Revue Therapeutique|December 13, 2003
[Pathophysiologic cardiovascular changes in stress and depression]L Spieker, G NollChest|July 1, 1982
Plasma adrenaline and noradrenaline in patients with acute myocardial infarction. Relationship to ventricular arrhythmias of varying severityO Bertel, F R Bühler, G Baitsch, et al.Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 3, 2004
Quality of life and exercise capacity in patients with prolonged PQ interval and dual chamber pacemakers: a randomized comparison of permanent ventricular stimulation vs intrinsic AV conductionD E Maurer, B Naegeli, E Straumann, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 1, 1991
Amyotrophic lateral sclerosis: glutamate dehydrogenase and transmitter amino acids in the spinal cordS Malessa, P N Leigh, O Bertel, et al.Schweizerische Medizinische Wochenschrift|November 8, 1980
[Accuracy of clinical findings in patients with disturbed myocardial function in acute myocardial infarction]O Bertel, G Baitsch, A M Steiner, et al.Schweizerische Medizinische Wochenschrift|December 14, 1985
[Does closely monitored control and therapy adjustment improve the prognosis in patients with severe heart insufficiency?]O Bertel, D Conen, U Schwarz, et al.Pacing and Clinical Electrophysiology : PACE|January 1, 1994
Importance of an individually programmed atrioventricular delay at rest and on work capacity in patients with dual chamber pacemakersJ Frielingsdorf, A E Gerber, P Dür, et al.Intensive Care Medicine|August 11, 2001
Elevation of troponin I in sepsis and septic shockP Ammann, T Fehr, E I Minder, et al.Praxis|May 24, 2000
[Pharmacoeconomic evaluation of pravastatin in coronary secondary prevention in patients with myocardial infarct or unstable angina pectoris. An analysis based on the LIPID Study]T D Szucs, O Bertel, R Darioli, et al.Pageof 33